CD163 and colorectal cancer: Based on cell fusion theory and the assumption that the macrophage–cancer cell fusion creates hybrids expressing phenotypic characteristics of macrophages, we reported in previous studies that the macrophage-specific marker, CD163, was expressed in breast and colorectal cancers.